EFFECT OF CAPTOPRIL OR ENALAPRIL ON RENAL PROSTAGLANDIN-E2

被引:11
作者
KATAYAMA, S
INABA, M
MARUNO, Y
OMOTO, A
ITABASHI, A
KAWAZU, S
ISHII, J
机构
关键词
D O I
10.1016/0090-6980(89)90123-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页码:401 / 411
页数:11
相关论文
共 23 条
[1]   ROLE OF PROSTAGLANDIN IN THE ANTIHYPERTENSIVE MECHANISM OF CAPTOPRIL IN LOW RENIN HYPERTENSION [J].
ABE, K ;
ITO, T ;
SATO, M ;
HARUYAMA, T ;
SATO, K ;
OMATA, K ;
HIWATARI, M ;
SAKURAI, Y ;
IMAI, Y ;
YOSHINAGA, K .
CLINICAL SCIENCE, 1980, 59 :S141-S144
[2]   RENAL PROSTAGLANDIN-E2 BIOSYNTHESIS - DEPENDENCE ON ANGIOTENSIN-II [J].
ATTALLAH, AA ;
STAHL, RAK ;
BLOCH, DL ;
AMBRUS, JL ;
LEE, JB .
AMERICAN JOURNAL OF CARDIOLOGY, 1982, 49 (06) :1521-1523
[3]  
ATTALLAH AA, 1987, J HYPERTEN S5, V5, pS209
[4]   DIFFERENCES IN RESPONSE TO THE PEPTIDYLDIPEPTIDE HYDROLASE INHIBITORS SQ-20,881 AND SQ-14,225 IN NORMAL-RENIN ESSENTIAL-HYPERTENSION [J].
CRANTZ, FR ;
SWARTZ, SL ;
HOLLENBERG, NK ;
MOORE, TJ ;
DLUHY, RG ;
WILLIAMS, GH .
HYPERTENSION, 1980, 2 (05) :604-609
[5]  
FITZ A, 1982, CLIN RES, V30, pA775
[6]  
JOHNSTON CI, 1979, LANCET, V2, P493
[7]   ACUTE EFFECTS OF MK421, A NEW ANGIOTENSIN CONVERTING ENZYME-INHIBITOR, IN MAN [J].
KASAI, Y ;
ABE, K ;
YASUJIMA, M ;
TAJIMA, J ;
SEINO, M ;
CHIBA, S ;
SATO, K ;
GOTO, T ;
OMATA, K ;
TANNO, M ;
YOSHINAGA, K .
TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 1983, 141 (04) :417-422
[8]  
KATAYAMA S, 1987, J LAB CLIN MED, V109, P711
[9]   HYPERTENSION IN EXPERIMENTAL DIABETES-MELLITUS - RENIN-PROSTAGLANDIN INTERACTION [J].
KATAYAMA, S ;
LEE, JB .
HYPERTENSION, 1985, 7 (04) :554-561
[10]  
KATAYAMA S, 1987, J LAB CLIN MED, V109, P504